NCT05067270View on ClinicalTrials.gov

A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 22, 2021

Primary Completion Date

December 6, 2021

Study Completion Date

December 6, 2021

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Sodium Citrate

Administered SC infusion.

DRUG

Treprostinil

Administered SC infusion.

DRUG

Humalog diluent

Administered SC infusion.

DRUG

Magnesium Chloride

Administered SC infusion.

Trial Locations (2)

41460

Profil Institut für Stoffwechselforschung, Neuss

55116

Profil Mainz, Mainz

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT05067270 - A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter